Suzanna L. Arcand - Concepedia

Author

Suzanna L. Arcand

McGill University Health Centre

Also Known As

Arcand, Suzanna L., S. L. Arcand, S.L. Arcand, SUZANNA L. ARCAND, Suzanna Arcand, Suzanna L Arcand, Suzanna L. Arcand

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

McGill University Health Centre McGill University Université de Montréal Centre Hospitalier de l’Université de Montréal Jewish General Hospital

About

Suzanna L. Arcand is an author at McGill University Health Centre specializing in medicine, oncology, and cancer genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	413
2	Pathology	8	8	329
3	Obstetrics	5	5	231
4	Cell Biology	3	3	138
5	Anatomy	1	1	30

Suzanna L. Arcand

Publications

Citations

H-Index

Page 1

	Year	Citations
Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours Ashley H. Birch, Suzanna L. Arcand, Kathleen Klein Oros, PLoS ONE Cancer PathologyGeneticsLow Malignant PotentialGynecologyPathology	2011	96
Breast Carcinoma–Associated Fibroblasts Rarely Contain p53 Mutations or Chromosomal Aberrations Abdel Hosein, Min Wu, Suzanna L. Arcand, Cancer Research	2010	84
Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer Isabelle J. Létourneau, Michael C. Quinn, Lu-Lin Wang, BMC Cancer	2012	76
A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population Moria H Belanger, Lena Dolman, Suzanna L. Arcand, Journal of Ovarian Research	2015	65
Characterization of three new serous epithelial ovarian cancer cell lines Véronique Ouellet, Magdalena Zietarska, Lise Portelance, BMC Cancer	2008	56
Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines Marie-Hélène Benoît, Thomas J. Hudson, Georges Maire, International Journal of Oncology Oncogenic AgentGeneticsPrimary CulturesXi LossCancer Genomics	2007	54
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGF?-RII, KRAS2, TP53 and/or CDNK2A V. Samouëlian, Christine M. Maugard, Marc Jolicoeur, Cancer Chemotherapy and Pharmacology Radiosensitivity ProfilesOncogenic AgentMedicinePathologyCancer Biology	2004	48
Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics Lisa F. Gamwell, Karen Gambaro, Maria Merziotis, Orphanet Journal of Rare Diseases	2013	46
Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 <i>BRCA1</i> and <i>BRCA2</i> mutations Kathleen Klein Oros, Parviz Ghadirian, Celia M.T. Greenwood, International Journal of Cancer	2004	45
The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome Paulina M. Wojnarowicz, Kathleen Klein Oros, Michael C. Quinn, PLoS ONE Tp53 MutationSomatic VariantTumor HeterogeneityGenomic LandscapeGenetics	2012	44

Page 1